Publications by authors named "Jan Drooger"

Claim this Profile
E
Early prediction of menopausal status after chemotherapy in women with early breast cancer in order to optimize adjuvant endocrine therapy.
Charissa van Zwol-Janssens, Mandy M van Rosmalen, Esther Oomen-de Hoop, Jan C Drooger, Annemieke van der Padt-Pruijsten

Breast· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial.
Noortje Verschoor, Manouk K Bos, Ingeborg E de Kruijff, Mai N Van, Jaco Kraan, Jan C Drooger

Breast Cancer Res Treat· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of (neo)adjuvant chemotherapy on long-term survival outcomes in patients with invasive lobular breast cancer treated with endocrine therapy: A retrospective cohort study.
Selin Öztekin, Maartje J Hooning, Carolien H M van Deurzen, Anne-Marie H P Dietvorst, Jan C Drooger

Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival.
Noortje Verschoor, Vanja de Weerd, Mai N Van, Jaco Kraan, Marcel Smid, Jan C Drooger

NPJ Breast Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Clinical Prediction Model for 1-Year Mortality in Patients With Advanced Cancer.
Catherine Owusuaa, Annemieke van der Padt-Pruijsten, Jan C Drooger, Joan B Heijns, Anne-Marie Dietvorst

JAMA Netw Open· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.
Nathalie I Bouwer, Tessa G Steenbruggen, Hánah N Rier, Jos J E M Kitzen, Carolien H Smorenburg, Jan C Drooger

Int J Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies.
Nathalie van den Tempel, Hanny Odijk, Netteke van Holthe, Kishan Naipal, Anja Raams, Jan C Drooger

Int J Hyperthermia· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Palliative HER2-Targeted Therapy in HER2-Positive Metastatic Breast Cancer Is Less Effective After Previous Adjuvant Trastuzumab-Based Therapy.
Hánah N Rier, Mark-David Levin, Joost van Rosmalen, Monique M E M Bos, Jan C Drooger

Oncologist· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.
Jan C Drooger, Harm van Tinteren, Steffen M de Groot, Albert J Ten Tije, Hiltje de Graaf

Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer.
Jan C Drooger, Bernadette A M Heemskerk-Gerritsen, Nyrée Smallenbroek, Cynthia Epskamp, Caroline M Seynaeve

Breast Cancer Res Treat· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.
Jan Drooger, Delal Akdeniz, Jean-Philippe Pignol, Linetta B Koppert, Danielle McCool

Breast Cancer Res Treat· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an UPLC-MS/MS method for the quantification of tamoxifen and its main metabolites in human scalp hair.
Jan C Drooger, Agnes Jager, Mei-Ho Lam, Mathilda D den Boer, Stefan Sleijfer

J Pharm Biomed Anal· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-guided dosing of anthracycline-cyclophosphamide-containing chemotherapy in patients with breast cancer: a feasibility study.
Jan C Drooger, Johanna M van Pelt-Sprangers, Corry Leunis, Agnes Jager, Felix E de Jongh

Med Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature.
Jan C Drooger, Maartje J Hooning, Caroline M Seynaeve, Margreet H A Baaijens, Inge Marie Obdeijn

Cancer Treat Rev· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denosumab in breast cancer treatment.
Jan C Drooger, Annemieke van der Padt, Stefan Sleijfer, Agnes Jager

Eur J Pharmacol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis